Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII

Patients with hemophilia A present with spontaneous and sometimes life-threatening bleeding episodes that are treated using blood coagulation factor VIII (fVIII) replacement products. Although effective, these products have limited availability worldwide due to supply limitations and product costs,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Spencer, H Trent, Denning, Gabriela, Gautney, Richard E, Dropulic, Boro, Roy, Andre J, Baranyi, Lajos, Gangadharan, Bagirath, Parker, Ernest T, Lollar, Pete, Doering, Christopher B
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2011
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3034847/
https://ncbi.nlm.nih.gov/pubmed/21081907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.239
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים